We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Fetal Monitor Safeguards High-Risk Pregnancies

By HospiMedica staff writers
Posted on 14 May 2007
A new fetal monitor, the size of a mobile phone, helps expectant mothers check on their baby's heart beat without having to go into hospital and be attached to a machine.

The Monica AN24 is a small, wearable, battery-powered fetal/maternal electrophysiologic monitor, which weighs less than 100 g. More...
The monitor, developed by researchers at the University of Nottingham (UK), is designed for extensive periods of non-intrusive passive monitoring outside of the hospital setting, offering an alternative to current obstetric practice. The device will also be useful in monitoring high-risk pregnancies.

The highly sensitive monitor can gauge the heart rates of mother and fetus, as well as fetal position. The monitor converts the electrical signals from the maternal abdomen into a digital format and processes the data to extract clinically relevant information, such as the fetal heart rate (FHR), maternal heart rate (MHR), and other parameters during pregnancy. A detachable lead is connected to five disposable electrodes placed on the maternal abdomen, in a configuration designed to support the correct placement of the electrodes; little or no skill is needed to position the electrodes and commence monitoring. The resulting data can be also be transmitted by wireless technology to the nearest personal computer (PC).

"The device will be especially helpful in monitoring fetuses whose mothers suffer from medical conditions such as diabetes, autoimmune conditions such as systemic lupus erythematosus and Sjogren's syndrome, and obstetric cholestasis,” said one of the developers, Dr. Margaret Ramsay of the School of Human Development. "For all these fetuses, the more we can monitor them, the greater the chance of us detecting that they are running into difficulties before it is too late to help them.”

The technology developed at the university was spun out to create Monica Healthcare (Nottingham, UK). The monitor has passed all European Union (EU) regulatory safety standards and is currently undergoing clinical trials.


Related Links:
University of Nottingham
Monica Healthcare

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Gold Member
Electrode Solution and Skin Prep
Signaspray
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.